Clinical trial
Randomized Controlled Trial of Different Behavioral Text Messages to Improve Influenza Vaccination Rates
NCT07372950 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Different Behavioral Text Messages to Improve Influenza Vaccination Rates
- Lead sponsor
- Kaiser Permanente
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 6, 2025
- Completion date
- September 1, 2026
- Enrollment
- 100,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza, vaccination